Anti capsid drugs HAP12 and AT130 target HBV core protein nuclear functions. (15th February 2015) - Belloni, L.; Palumbo, G.A.; Li, L.; Chirapu, S.R.; Calvo, L.; Lupacchini, L.; Finn, M.G.; Lopatin, U.; Zlotnick, A.; Levrero, M.